The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity

Journal of Virology

Volumn 76, Issue 4, 2002, Pages 2014-2018

  Dorsch, Simone ^a   Liebisch, Gerhard ^a   Kaufmann, Bärbel ^a   Von Landenberg, Philipp ^a   Hoffmann, Jörg H ^a   Drobnik, Wolfgang ^a   Modrow, Susanne ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOLIPASE A2; PROTEIN VP1;

AMINO TERMINAL SEQUENCE; ARTICLE; ENZYME ACTIVITY; ERYTHEMA INFECTIOSUM; NONHUMAN; PARVOVIRUS; PHOSPHOLIPID MEMBRANE; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; TANDEM MASS SPECTROMETRY; VIRUS CAPSID; VIRUS NEUTRALIZATION; VIRUS PARTICLE; VIRUS RECOMBINANT;

AMINO ACID SEQUENCE; CAPSID; CAPSID PROTEINS; ESCHERICHIA COLI; HUMANS; KINETICS; PARVOVIRUS B19, HUMAN; PHOSPHOLIPASES A; SEQUENCE HOMOLOGY, AMINO ACID; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; VIRION;

EID: 0036148234     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.4.2014-2018.2002     Document Type: Article

References (25)

1. Phospholipase A2 - A structural review
2. The importance of glycine-30 for enzymatic activity of phospholipase A2
3. A rapid method of total lipid extraction and purification
4. Erythrocyte P antigen: Cellular receptor for B19 parvovirus
5. Intrauterine parvovirus infection associated with hydrops fetalis
6. Quantitative analysis of biological membrane lipids at the low picomole level by nano-electrospray ionization tandem mass spectrometry
7. Presence and significance of human parvovirus B19 DNA in synovial membranes and bone marrow from patients with arthritis of unknown origin
8. The VP1-unique region of parvovirus B19: Amino acid variability and antigenic stability
9. Generation of neutralizing human monoclonal antibodies against parvovirus B19 proteins
10. Prevalence of NS1-specific antibodies in patients infected with parvovirus B19 and in pregnant women
11. Evidence for the involvement of tyrosine-69 in the control of stereospecificity of porcine pancreatic phospholipase A2
12. Receptors for a growing family of secreted phospholipases A2
13. Genome organization of the densovirus from Bombyx mori (BmDNV-1) and enzyme activity of its capsid
14. A cytotoxic nonstructural protein, NS1, of human parvovirus B19 induces activation of interleukin-6 gene expression
15. Parvovirus-associated arthritis
16. Parvovirus infection mimicking systemic lupus erythematosus in a pediatric population
17. Phospholipase A2 enzymes: Regulation and physiological role
18. Transient erythroblastopenia of childhood with megakaryocytopenia associated with human parvovirus B19 infection
19. Rheumatologic manifestations of human parvovirus B19 infection in adults. Initial two-year clinical experience
20. Hemmer der Phospholipase A2
21. Chronic autoimmune thrombopenia/neutropenia in a boy with persistent parvovirus B19 infection
22. Detection of multiple viral DNA species in synovial tissue and fluid of patients with early arthritis
23. Human parvovirus B19 as a causative agent for rheumatoid arthritis
24. The role of Asp-49 and other conserved amino acids in phospholipases A2 and their importance for enzymatic activity
25. A viral phospholipase A2 is required for parvovirus infectivity